EZH2 and chronic myelogenous leukemia, BCR-ABL1 positive: This was shown to be associated with a reprogramming of H3K27me3 at PRC2 target genes, resulting in altered dependency on EZH2 for survival in CML LSCs compared to normal cells (Scott et al., 2016; Xie et al., 2016; Figure 1).